AKT1 and glioblastoma: To investigate whether LGMN-induced GBM cell proliferation is regulated by the AKT/p65 pathway, we first optimized the concentration of the AKT inhibitor LY294002 and the p65 inhibitor SC75741 in SF763, LN229, U87, and CT2A cells (Supplemental Figure 7, A–H).